Background Good glycaemic control in type 2 diabetes can reduce both morbidity and mortality, and monitoring of glycated haemoglobin A 1c (HbA 1c ) is currently recommended for this purpose.
Introduction
The incidence and prevalence of type 2 diabetes in Australian Aborigines is higher than in any other ethnic group in Australia. 1 Because of the remoteness of some Aboriginal communities, a reliable and portable point-of-care instrument would prove very useful in the management of diabetes. The DCA 2000 ‡ analyser (Bayer Diagnostics, USA) is capable of measuring haemoglobin A 1c (HbA 1c ) values in only 6 min.
According to the American Diabetes Association, the percentage HbA 1c should be 56.0% in normal individuals, and the goal for individuals with diabetes is 57.0%. 2 We were interested in comparing HbA 1c measured on the DCA 2000 ‡ in a remote Aboriginal community with that measured in the laboratory using validated methodology.
Methods
Subjects (nˆ39) were aged between 18 and 71 years, and lived in the Galiwinku Community on Elcho Island, o¡ the coast of the Northern Territory. Venepuncture was performed after an overnight fast, and blood was drawn directly into evacuated tubes containing EDTA as an anticoagulant, using aseptic precautions. Haemoglobin A 1c (%) was measured using the DCA 2000 ‡ analyser in subjects with a fasting blood glucose concentration, measured using a glucometer, that suggested impaired fasting glucose or diabetes. The remainder of the samples were stored in a liquid nitrogen Biological Shipper (CryoPak Series,Taylor-Wharton AL, USA) for analysis of HbA 1c in the laboratory.
The DCA 2000 ‡ measures HbA 1c using an immunological reaction, in which glycated haemoglobin competes for limited antibody-latex binding sites, and consequently changes the light absorbance at 531nm. Patients' results are quanti¢ed using a calibration curve of absorbance versus percentage HbA 1c concentration. 3 The DCA 2000 ‡ displays results between 2.5% and 14.0% and does not provide any dilution method for results above 14.0%. The reagent kit uses 1 mL of whole blood and a reading is obtained through an optical window (Bayer DCA2000 Hemoglobin A 1c Reagent Kit). The mean maximum temperature was 308C and relative humidity was approximately 80% throughout the study, as recorded by the Bureau of Meteorology.
The laboratory measurement of HbA 1c in the samples from the same vial as that used for DCA 2000 ‡ measurement was performed by SouthPath Laboratory, Flinders Medical Centre, South Australia, using cation-exchange high-performance liquid chromatography (HPLC) on a Pharmacia MonoS column. 4 The mean intra-and inter-assay coe¤cients of variation for the DCA 2000 ‡ and HPLC methods were 53%, similar to that reported in the literature.
Ethical approval
This study was performed as part of an NHMRCfunded study entitled`Community-based interventions to reduce the risk of diabetes and cardiovascular disease in indigenous Australians'. Ethical approval for the project was given by the Joint Institutional Ethics Committee of Royal Darwin Hospital and the Menzies School of Health Research.
Statistical methods
Data are presented as mean and 95% con¢dence interval (CI), unless otherwise stated, and were analysed using commercial software (Stata Version 7, Stata Corp TX, USA 
Results
Haemoglobin A 1c (%) measurements on the DCA 2000 ‡ and in the laboratory (nˆ39) were log-transformed to obtain a normal distribution. The values ranged from 4.7 to 12.3% with the DCA 2000 ‡ method and from 4.7 to 12.4% with the HPLC method. Mean (95% CI) HbA 1c results measured on the DCA 2000 ‡ and in the laboratory were 6.3% (5.8, 6.9%) and 6.5% (6.0, 7.0%), respectively, with a correlation coe¤cient rˆ0.96 (P50.01). The mean HbA 1c values were not signi¢cantly di¡erent (P40.05).
The di¡erence in results between the two methods was plotted against the mean of the two methods (see Fig. 1 ). The bias and mean of the two estimates were not signi¢cantly correlated (rˆ0.06; P40.05). The mean bias in HbA 1c was 70.1% (DCA 2000 ‡ versus laboratory), with lower and upper LOA of 71.1% and 0.8%, respectively. Sensitivity of the DCA 2000 ‡ was 100% (exact binomial one-sided 97.5% CI: 72%, 100%), as was speci¢city (exact binomial one-sided 97.5% CI: 88%, 100%) and PPV (exact binomial onesided 97.5% CI: 72%, 100%). 
Conclusion
This study shows that the Bayer DCA 2000 ‡ accurately measures HbA 1c (%) in a remote Aboriginal community. This reasonably priced instrument can provide useful information for the management of patients with diabetes. Moreover, non-medical sta¡ with minimal technical expertise can operate this analyser. The DCA 2000 ‡ is unable to measure HbA 1c values above 14%. However, this is unlikely to constitute a major problem as an out-of-range value is su¤-cient information for further management of the individual. Although the performance characteristics of the DCA 2000 ‡ appear very promising, more studies with a larger sample size are necessary.
